Lombardi G, Matera R, Minervini M M, Cascavilla N, D'Arcangelo P, Carotenuto M, Di Giorgio G, Musto P
Division of Hematology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy.
Haematologica. 1994 Sep-Oct;79(5):406-12.
A series of immunological abnormalities has been described in patients with beta-thalassemia. The aim of this study was to investigate whether the measurement of serum levels of selected cytokines and soluble molecules (deriving from cell membrane antigens) involved in the immune response could be useful for a better definition of such alterations.
Serum levels of interleukin-2 (IL-2), IL-6, tumor necrosis factor (TNF), soluble (s) CD4, sCD8, sCD23 and sCD25 were measured using immunoenzymatic assays in 45 transfusion-dependent patients affected by beta-thalassemia major and correlated to conventional immunological indexes, such as peripheral lymphocyte subpopulations and circulating immunoglobulins.
Patients with beta-thalassemia major showed increased TNF, sCD8, sCD23 and sCD25 and lower sCD4 values compared to normal controls. IL-2 and IL-6 were found to be undetectable or within the normal range in all patients. Splenectomized patients presented lower levels of sCD8 and sCD23 than those observed in unsplenectomized ones. A series of correlations involving TNF, sCD8, sCD23, sCD25, serum immunoglobulins and some lymphocyte subpopulations was observed. In addition, serum markers of immune activation (TNF, sCD23, sCD25) correlated directly with the annual blood transfusion requirement. Despite this series of immunological anomalies, no patient had a history of repeated infectious episodes.
Polytransfused beta-thalassemic patients are characterized by a partial functional immunodeficiency determined by increased activity of CD8+ suppressor/cytotoxic lymphocytes and possibly reduced activity of the CD4+ helper/inducer subset. B-lymphocytes also appear highly activated. The allo-antigenic stimulation of transfusions seems to play a major role in the determination of these defects; however, this functional immunological imbalance does not seem to have any clinical relevance.
β地中海贫血患者存在一系列免疫异常。本研究旨在探讨检测参与免疫反应的特定细胞因子和可溶性分子(源自细胞膜抗原)的血清水平是否有助于更好地界定此类改变。
采用免疫酶法检测45例重型β地中海贫血依赖输血患者的血清白细胞介素-2(IL-2)、IL-6、肿瘤坏死因子(TNF)、可溶性(s)CD4、sCD8、sCD23和sCD25水平,并与传统免疫指标(如外周淋巴细胞亚群和循环免疫球蛋白)进行相关性分析。
与正常对照组相比,重型β地中海贫血患者的TNF、sCD8、sCD23和sCD25水平升高,sCD4值降低。所有患者的IL-2和IL-6均未检测到或在正常范围内。脾切除患者的sCD8和sCD23水平低于未行脾切除者。观察到一系列涉及TNF、sCD8、sCD23、sCD25、血清免疫球蛋白和一些淋巴细胞亚群的相关性。此外,免疫激活的血清标志物(TNF、sCD23、sCD25)与年度输血需求量直接相关。尽管存在这一系列免疫异常,但无患者有反复感染发作史。
多次输血的β地中海贫血患者的特征是存在部分功能性免疫缺陷,这是由CD8 +抑制/细胞毒性淋巴细胞活性增加以及可能的CD4 +辅助/诱导亚群活性降低所决定的。B淋巴细胞也似乎高度激活。输血的同种异体抗原刺激似乎在这些缺陷的形成中起主要作用;然而,这种功能性免疫失衡似乎没有任何临床相关性。